Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.
A cell therapy strategy utilizing genetically-corrected induced pluripotent stem cells (iPSC) may be an attractive approach for genetic disorders such as muscular dystrophies. Methods for genetic engineering of iPSC that emphasize precision and minimize random integration would be beneficial. We dem...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096279&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850192094424989696 |
|---|---|
| author | Chunli Zhao Alfonso P Farruggio Christopher R R Bjornson Christopher L Chavez Jonathan M Geisinger Tawny L Neal Marisa Karow Michele P Calos |
| author_facet | Chunli Zhao Alfonso P Farruggio Christopher R R Bjornson Christopher L Chavez Jonathan M Geisinger Tawny L Neal Marisa Karow Michele P Calos |
| author_sort | Chunli Zhao |
| collection | DOAJ |
| description | A cell therapy strategy utilizing genetically-corrected induced pluripotent stem cells (iPSC) may be an attractive approach for genetic disorders such as muscular dystrophies. Methods for genetic engineering of iPSC that emphasize precision and minimize random integration would be beneficial. We demonstrate here an approach in the mdx mouse model of Duchenne muscular dystrophy that focuses on the use of site-specific recombinases to achieve genetic engineering. We employed non-viral, plasmid-mediated methods to reprogram mdx fibroblasts, using phiC31 integrase to insert a single copy of the reprogramming genes at a safe location in the genome. We next used Bxb1 integrase to add the therapeutic full-length dystrophin cDNA to the iPSC in a site-specific manner. Unwanted DNA sequences, including the reprogramming genes, were then precisely deleted with Cre resolvase. Pluripotency of the iPSC was analyzed before and after gene addition, and ability of the genetically corrected iPSC to differentiate into myogenic precursors was evaluated by morphology, immunohistochemistry, qRT-PCR, FACS analysis, and intramuscular engraftment. These data demonstrate a non-viral, reprogramming-plus-gene addition genetic engineering strategy utilizing site-specific recombinases that can be applied easily to mouse cells. This work introduces a significant level of precision in the genetic engineering of iPSC that can be built upon in future studies. |
| format | Article |
| id | doaj-art-1e626ec91aca44caa7954e946e2d2f9a |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-1e626ec91aca44caa7954e946e2d2f9a2025-08-20T02:14:41ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9627910.1371/journal.pone.0096279Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells.Chunli ZhaoAlfonso P FarruggioChristopher R R BjornsonChristopher L ChavezJonathan M GeisingerTawny L NealMarisa KarowMichele P CalosA cell therapy strategy utilizing genetically-corrected induced pluripotent stem cells (iPSC) may be an attractive approach for genetic disorders such as muscular dystrophies. Methods for genetic engineering of iPSC that emphasize precision and minimize random integration would be beneficial. We demonstrate here an approach in the mdx mouse model of Duchenne muscular dystrophy that focuses on the use of site-specific recombinases to achieve genetic engineering. We employed non-viral, plasmid-mediated methods to reprogram mdx fibroblasts, using phiC31 integrase to insert a single copy of the reprogramming genes at a safe location in the genome. We next used Bxb1 integrase to add the therapeutic full-length dystrophin cDNA to the iPSC in a site-specific manner. Unwanted DNA sequences, including the reprogramming genes, were then precisely deleted with Cre resolvase. Pluripotency of the iPSC was analyzed before and after gene addition, and ability of the genetically corrected iPSC to differentiate into myogenic precursors was evaluated by morphology, immunohistochemistry, qRT-PCR, FACS analysis, and intramuscular engraftment. These data demonstrate a non-viral, reprogramming-plus-gene addition genetic engineering strategy utilizing site-specific recombinases that can be applied easily to mouse cells. This work introduces a significant level of precision in the genetic engineering of iPSC that can be built upon in future studies.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096279&type=printable |
| spellingShingle | Chunli Zhao Alfonso P Farruggio Christopher R R Bjornson Christopher L Chavez Jonathan M Geisinger Tawny L Neal Marisa Karow Michele P Calos Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. PLoS ONE |
| title | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. |
| title_full | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. |
| title_fullStr | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. |
| title_full_unstemmed | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. |
| title_short | Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. |
| title_sort | recombinase mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096279&type=printable |
| work_keys_str_mv | AT chunlizhao recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT alfonsopfarruggio recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT christopherrrbjornson recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT christopherlchavez recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT jonathanmgeisinger recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT tawnylneal recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT marisakarow recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells AT michelepcalos recombinasemediatedreprogramminganddystrophingeneadditioninmdxmouseinducedpluripotentstemcells |